GleamWall
中文EN

NGVT Ingevity Corp

Chemicals & Allied Products · NYSE · SEC CIK 1653477 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.7%
TTM net income YoY190.7%
TTM EPS YoY196.1%
Revenue 3-yr CAGR-12.7%
Net income 3-yr CAGR-22.2%

Margins

Gross margin42.0%
Operating margin—
Net margin5.3%
FCF margin10.8%
EBITDA margin—

Returns

ROE59.5%
ROA3.6%
ROIC (approx.)—
Asset turnover0.68x

Leverage & solvency

Liabilities / assets95.8%
Debt / equity18.18x
Current ratio1.48x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.02x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue5.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$305.10M$314.10M$258.00M$255.10M$333.10M$331.50M$247.90M$263.30M
Cost of revenue$172.30M$175.10M$141.60M$167.30M$199.20M$203.70M$136.00M$163.40M
Gross profit$132.80M$139.00M$116.40M$87.80M$133.90M$127.80M$111.90M$99.90M
R&D expense$8.30M$6.10M$6.70M$7.40M$7.00M$7.00M$7.00M$6.50M
SG&A expense$38.10M$39.00M$40.70M$41.60M$44.10M$43.60M$41.90M$38.30M
Operating income———————$80.60M
Pretax income$68.90M$50.70M$30.20M-$105.30M$62.20M-$136.60M$37.60M$24.10M
Income tax$17.80M$10.90M$6.80M-$26.60M$21.40M$4.80M$8.50M$4.50M
Net income$49.30M$35.30M$59.80M-$84.60M$43.50M-$146.50M$20.50M$16.60M
EBITDA———————$105.80M
EPS (basic)1.441.021.70—1.20-4.020.56—
EPS (diluted)1.411.001.66—1.18-4.020.56—
Weighted avg. shares (diluted)34.85M35.28M36.02M—36.95M36.46M36.66M—
Balance sheet
Cash & equivalents$85.40M$97.40M$95.40M$78.10M$83.40M$76.90M$71.50M$68.00M
Inventory$153.90M$154.00M$203.60M$186.00M$193.70M$220.30M$245.40M$195.90M
Current assets$531.70M$543.80M$581.80M$454.20M$522.20M$536.00M$530.00M$493.20M
PP&E, net$572.40M$575.00M$599.80M$608.10M$629.70M$654.60M$655.80M$642.90M
Goodwill$4.30M$4.30M$4.30M$4.30M$4.30M$4.30M$180.70M$175.20M
Intangibles$133.20M$137.30M$168.00M$176.10M$267.60M$279.10M$276.80M$278.80M
Total assets$1.50B$1.54B$1.65B$1.65B$1.83B$1.88B$2.06B$2.02B
Current liabilities$359.00M$337.60M$409.40M$341.30M$411.60M$393.10M$264.60M$264.10M
Short-term debt$156.40M$144.00M$121.90M$47.10M$102.00M$94.70M$60.40M$61.30M
Long-term debt$989.10M$1.06B$1.08B$1.16B$1.16B$1.24B$1.33B$1.34B
Total debt$1.15B$1.20B$1.20B$1.21B$1.26B$1.33B$1.39B$1.40B
Total liabilities$1.44B$1.49B$1.61B$1.62B$1.70B$1.76B$1.82B$1.83B
Shareholders' equity$63.00M$46.90M$38.90M$29.70M$138.10M$120.70M$234.60M$195.20M
Net debt$1.06B$1.10B$1.11B$1.13B$1.18B$1.25B$1.32B$1.33B
Shares outstanding33.96M34.48M34.89M35.49M36.05M36.47M36.45M36.35M
Cash flow statement
Operating cash flow$99.20M-$13.80M-$2.00M$97.10M$129.70M$79.00M$25.40M$64.50M
Capital expenditure$13.70M$10.30M$10.30M$23.60M$11.90M$12.20M$10.00M$24.90M
Free cash flow$85.50M-$24.10M-$12.30M$73.50M$117.80M$66.80M$15.40M$39.60M
Investing cash flow-$11.20M$75.40M$106.30M-$15.10M-$28.10M-$2.80M-$11.50M-$28.00M
Financing cash flow-$93.70M-$37.60M-$61.80M-$83.40M-$94.80M-$63.00M-$11.00M-$97.60M
Depreciation & amortization$20.90M$22.00M$22.70M$27.90M$28.00M$25.60M$24.90M$25.20M
Stock-based compensation$4.00M$4.20M$4.80M$4.50M$5.30M$4.40M$4.10M$2.10M
Share buybacks$38.50M$34.50M$52.30M$31.10M$25.20M$0$0$0

Free plan shows the latest 8 periods; Pro shows all 47 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.